 

FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

FDA White Oak Campus, Building 31, The Great Room (Rm. 1503) 

White Oak Conference Center, Silver Spring, Maryland 

 

 

October 18, 2012 

MEETING ROSTER 

 

Robert J. Smith, MD 
Professor of Medicine (Endocrinology) 
Alpert Medical School of Brown University 
East Providence, Rhode Island 
 
 

DESIGNATED FEDERAL OFFICER (Non-Voting)  
 
Paul T. Tran, RPh  
Division of Advisory Committee and Consultant Management  
Office of Executive Programs, CDER, FDA 
 
ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE MEMBERS 
(Voting) 
                                                                                                  
Erica H. Brittain, PhD 
Mathematical Statistician  
Biostatistics Research Branch 
National Institute of Allergy and Infectious 
Diseases (NIAID) 
National Institutes of Health (NIH) 
Bethesda, Maryland 
 
Edward W. Gregg, PhD 
Chief, Epidemiology and Statistics Branch 
Division of Diabetes Translation 
Centers for Disease Control and Prevention (CDC) 
Atlanta, Georgia  
 
ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE MEMBER (Non-
Voting) 
 
Mads F. Rasmussen, MD, PhD 
(Industry Representative) 
Executive Director 
Diabetes - Clinical Development and Research 
Clinical Development, Medical and Regulatory 
Affairs, Novo Nordisk Inc.  
Princeton, New Jersey 
 

Ida J. Spruill, PhD, RN  
(Consumer Representative) 
Assistant Professor, College of Nursing 
Medical University of South Carolina 
Charleston, South Carolina 
 

 

Page 1 of 3 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

 

October 18, 2012 

MEETING ROSTER (cont.) 

 

 
 
TEMPORARY MEMBERS (Voting) 
 
Alexander G. Caleb, MD 
Associate Professor of Epidemiology & Medicine  
Johns Hopkins Bloomberg School of Public Health 
Baltimore, Maryland 

Hari S. Conjeevaram, MD  
Associate Professor of Medicine, 
Program Director, GI Fellowship Program, 
Division of Gastroenterology  
Medical Director, Student Run Free Clinic  
University of Michigan 
Ann Arbor, Michigan 
 
David W. Cooke, MD 
Associate Professor of Pediatrics 
Division of Pediatric Endocrinology 
Director, Pediatric Endocrine Fellowship Training 
Program  
Johns Hopkins University School of Medicine 
Baltimore, Maryland 

David J. Gordon, MD, PhD, MPH  
Special Assistant for Clinical Studies 
Cardiovascular Clinical Trials 
Division of Cardiovascular Sciences 
National Heart, Lung, and Blood Institute 
(NHLBI), NIH 
Bethesda, Maryland 
 
Susan R. Heckbert, MD, PhD 
Professor of Epidemiology 
University of Washington  
Cardiovascular Health Research Unit 
Seattle, Washington 
 
 
 
 

Page 2 of 3 

Joel E. Lavine, MD, PhD 
Professor of Pediatrics 
Chief, Pediatric Gastroenterology, Hepatology and 
Nutrition Columbia University 
New York, New York 
 
David E. Malarkey, DVM, PhD, DACVP 
Head, National Toxicology Program Pathology 
Group 
Cellular and Molecular Pathology Branch 
National Institute of Environmental Health 
Sciences (NIEHS), NIH 
Research Triangle Park, North Carolina 
 
Jeffrey B. Schwimmer, MD 
Professor of Pediatrics 
Division of Gastroenterology, Hepatology, and 
Nutrition 
Department of Pediatrics  
University of California, San Diego  
San Diego, California 
 
Abraham Thomas, MD, MPH, FACP 
(Acting Chairperson) 
Division Head, Endocrinology, Diabetes, Bone, 
and Mineral Disorders 
Henry Ford Hospital 
Whitehouse Chair of Endocrinology 
Detroit, Michigan  
 
Marlena Vega, PhD  
(Patient Representative) 
New York, New York 
 

FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

 

October 18, 2012 

MEETING ROSTER (cont.) 

 

 
 
TEMPORARY MEMBERS (Voting) 
 
Peter W.F. Wilson, MD 
Professor of Medicine 
Emory University  
School of Medicine 
Department of Cardiology 
Atlanta, Georgia 
 
FDA PARTICIPANTS (Non-Voting) 
 
Christine P. Nguyen, MD 
Acting Deputy Director 
Office of Drug Evaluation II (ODE-II)  
Office of New Drugs (OND), CDER, FDA 
 
Eileen Craig, M.D. 
Clinical Reviewer 
DMEP, ODE-II, OND, CDER, FDA 
 

 

 

 

  
 

Eric C. Colman, MD 
Deputy Director 
Division of Metabolism and Endocrinology 
Products (DMEP), ODE-II, OND, CDER, FDA 
 
Claudia B. Manzo, PharmD 
Director  
Division of Risk Management (DRISK) 
Office of Medication Error Prevention and Risk 
Management (OMEPRM) 
Office of Surveillance and Epidemiology (OSE) 
CDER, FDA 
 
 

Page 3 of 3 

